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Abstract
Toxoplasma gondii seroprevalence was determined in 3333 sheep sera from 125 distinct sheep flocks in Scotland,
with the majority of flocks being represented by 27 samples, which were collected between July 2006 and August
2008. The selected farms give a representative sample of 14 400 sheep holdings identified in the Scottish
Government census data from 2004. Overall T. gondii seroprevalence, at individual sheep level, was determined to
be 56.6%; each flock tested, had at least a single positive animal and in four flocks all ewes tested positive. The
seroprevalence of sheep increased from 37.7% in one year old stock to 73.8% in ewes that were older than six
years, showing that acquired infections during the life of the animals is frequent and that environmental
contamination by T. gondii oocysts must be significant. The median within-flock seroprevalence varied significantly
across Scotland, with the lowest seroprevalence of 42.3% in the South and the highest seroprevalence of 69.2% in
the far North of Scotland and the Scottish Islands, while the central part of Scotland had a seroprevalence of
57.7%. This distribution disequilibrium may be due to the spread and survival of oocysts on pasture and lambing
areas. A questionnaire accompanying sampling of flocks identified farms that used Toxovax®, a commercial vaccine
that protects sheep from abortion due to T. gondii infection. Only 24.7% of farmers used the vaccine and the
vaccine did not significantly affect the within flock seroprevalence for T. gondii. The implications for food safety
and human infection are discussed.
Introduction
Toxoplasma gondii is the most successful parasitic
pathogen world-wide, infecting all warm blooded ani-
mals including humans [1]. This protozoan parasite is of
great economic importance to the sheep industry. In the
UK, T. gondii was shown to be the second most com-
monly diagnosed cause of abortions in sheep (25.4%),
after Chlamydophila abortus (45.6%), based on data
from Veterinary Investigation Diagnosis Analysis
(VIDA) for 2009 [2]. The scope for clinical toxoplasmo-
sis is great; in the UK alone there are 14.2 million
sheep, of which 6.5 million are breeding ewes [3]. Using
average annual incidence rates of clinical toxoplasmosis
of between 1% and 2% [4], this would mean that
between 65 000 and 130 000 pregnancies are lost
annually due to T. gondii infection in the UK alone,
while in European Union, with a total number of 68.1
million breeding ewes [5] the loss would be between
680 000 and 1 360 000 pregnancies annually.
Most T. gondii infections in sheep occur through the
ingestion of oocysts, a stage of the parasite, which is
very stable and can survive in favourable conditions in
the environment for over 12 months, contaminating
pasture, feeds and drinking water [6]. Oocysts are pro-
duced in the definitive hosts of T. gondii, cats, which
shed the parasite in their faeces after eating meat,
infected with tissue cysts [7]. Intermediate hosts, includ-
ing sheep and humans, that ingest oocysts are thought
to become infected for life, with detectable and persis-
tent IgG antibody levels specific for T. gondii and this
has aided the assessment of infection levels in many
host species [8].
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Abortions in sheep due to T. gondii are associated
with a primary infection during the first or second tri-
mester of gestation, while primary infection in the later
stages of pregnancy leads to the birth of congenitally
infected lambs, which are relatively rare [9,10]. Infected
animals develop an effective immune response, which
will protect against disease in subsequent pregnancies
[11]. These studies and others showed that vaccination
may be a feasible option to control disease and lead to
the development of a live vaccine preparation. Toxovax®
was licensed in 1988 in New Zealand and was launched
in 1992 in UK and Ireland [12]. Toxovax® consists of a
live attenuated T. gondii strain (S48) that will not cause
a persistent infection [13,14]. The efficacy and safety of
this vaccine were tested by Intervet B.V. in collaboration
with the Moredun Research Institute in Scotland, where
it was shown that a single vaccine dose will induce an
effective immune response that will persist for at least
18 months without further challenge [15].
Human congenital infections with T. gondii are very
similar to those seen in pregnant sheep but there are no
licensed vaccines for humans that protect against toxo-
plasmosis. Another difference is the main transmission
route by which humans may become infected [16]. A
multicentre epidemiologic study among pregnant
women in Europe identified ingestion of raw or under-
cooked meat/meat-products, containing tissue cysts, as
the major source of T. gondii infection, while infection
through oocysts, from environmental contamination,
plays only a minor part [17].
In 2007, 1851 cases of T. gondii infection in humans
were clinically diagnosed and reported by 18 European
Union member states, 149 of which originated from the
United Kingdom [18], giving an incidence rate of 0.83
reported clinical cases per 100 000 people within Eur-
ope. Although this incidence seems low, this does not
express the severity of the potential consequence of
infection, which could be abortion or the birth of conge-
nitally infected babies, which may suffer from learning
disabilities, requiring assistance throughout life; these
congenitally infected children are likely to develop ocu-
lar toxoplasmosis later in life. Therefore the resulting
disease burden, due to T. gondii infection, was rated
higher than that of any other food borne pathogens in
Europe, by the National Institute of Public Health and
the Environment (RIVM) of The Netherlands [19,20]. In
another recent report by the RIVM, based on calcula-
tions of the long-term socio-economic impact of emer-
ging zoonotic pathogens relevant for The Netherlands,
T. gondii was ranked as the second most important
pathogen due to its high disease burden [21].
The European food safety authority recommended in
2007, that there is a need to improve data collection on
surveillance and monitoring of T. gondii in animals and
food products for human consumption, in order to bet-
ter evaluate the disease risk of toxoplasmosis in member
states [22]. There is no current data on the prevalence
of T. gondii in food animals in the UK and very little is
known about environmental contamination levels of T.
gondii oocysts. Existing prevalence figures are only
regional and predate the licensing of Toxovax® in the
UK. In this study we set out to ascertain how frequent
T. gondii infections are within a representative section
of Scottish sheep flocks, when sheep become infected
and how widely Toxovax® is used.
Materials and methods
Study design and serum collection
The serum samples for the T. gondii prevalence study
stem from a national study, aimed to assess the preva-
lence of different endemic sheep diseases in Scotland,
conducted between July 2006 and August 2008 [23].
The sample frame comprising 825 sheep holdings was
generated on the basis of Scottish Government census
data from June 2004 and was stratified by three separate
regions (South (i.e. south of Glasgow and Edinburgh),
Central (i.e. Aberdeenshire, Perthshire and Argyll) and
North (i.e. Highlands and Islands) consisting of 40, 35
and 50 farms, respectively) to take account of the distri-
bution of sheep of different Scottish regions. Flocks with
at least 50 breeding ewes were eligible to take part in
the study; on farms that had multiple flocks, information
was gathered only for one flock. Study farms were initi-
ally contacted by mail and then by telephone to identify
farmers willing to participate in the study. On 125 farms
information was gathered on general farm characteris-
tics, management practices and animal health during a
face-to-face interview; the standardised questionnaire
had been designed with the help of sheep specialists and
was pre-tested on 5 sheep owners. At the end of the
interview farmers were given a printout of the question-
naire for a crosscheck to ensure optimal data quality. A
postal follow-up questionnaire including specific ques-
tions on the use of Toxovax®, a commercially available
vaccine against toxoplasmosis, was also conducted. Age
and breed were recorded for typically 27 sheep per flock
from which serum samples were taken. The samples
were sent to the laboratory by next day delivery at ambi-
ent temperature and serum was separated from clotted
blood and stored at -20 C until tested.
Serology
An ELISA was used to detect IgG antibodies to T. gon-
dii in sheep sera as described by Buxton and colleagues
[24]. This ELISA used a water-soluble antigen fraction
of T. gondii tachyzoites of the S48 strain [25]. Data was
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expressed as percentage positivity in comparison to a
standard, high titre, positive control serum obtained
from an experimentally infected animal. Optical density
(OD) readings, resulting in a percentage positivity under
25% were considered to be negative; percentage positiv-
ity values of 25% and under 30% were classified as bor-
derline and percentage positivity values of 30% and
above were interpreted as positive [24]. Sera were tested
in duplicate and results that did not match or borderline
results were repeated.
Statistical analysis
Data were described using graphs and boxplots pro-
duced in MS Office Excel (version 2007) and R (version
2.12.0). Univariate tests of equality were performed at
animal level (age) and flock level (geographic region,
management practices). Individual animals were treated
as independent. Differences between strata of varied
management practices and geographic regions were
assessed by Wilcoxon-Mann-Whitney test; confidence
bands were calculated using bootstrapping methods
[26]. Linear regression models were used to assess the
association of age with serostatus of individual animals
as well as geographic latitude with within-flock seropre-
valence. Variables identified at the univariate stage of
analysis were included in multivariate regression models
and non-significant variables were removed in a step-
wise fashion. For variables with multiple categories, all
categories were maintained in model if one category
proved significant. The final model selection was based
on the Akaike information criterion (AIC), as well as




A total of 3333 sheep serum samples were collected
from 125 farms (between 25 and 31 samples per farm,
with the majority of farms (n = 109) being represented
by 27 sera), spread across Scotland to give a representa-
tive serum panel. A total of 1712 serum samples tested
positive for T. gondii antibodies, while 310 samples gave
a borderline result and 1311 sera were negative. At ani-
mal level, this resulted in an overall seroprevalence of
51.4%, counting the borderline results as negative. Due
to the difficulty of interpreting the borderline case
results it was decided to exclude them from subsequent
statistical analyses, resulting in a T. gondii prevalence of
56.6%. All study farms had T. gondii seropositive sheep,
varying from single animals (3.7%; one out of 27 ani-
mals) on four farms to farms (n = 4) where all sheep
sampled were positive (100%). Figure 1 presents the geo-
graphical distribution of the study farms across Scotland
and their T. gondii seroprevalence.
Effect of vaccination on T. gondii seroprevalence
The follow-up questionnaire data were analysed in order
to evaluate if the use of Toxovax®, a commercially avail-
able vaccine against toxoplasmosis, had a significant
impact on the seroprevalence shown above. Question-
naires were returned by 93 of the 125 farmers, with an
equal response rate across the different regions. The
vaccine was used by 22 of the 93 farmers that responded
(24.7%). In most cases the farmers used the vaccine on a
yearly basis (n = 16) to vaccinate their replacement
stock, while the remaining farmers used the vaccine less
frequently. The vaccine uptake was about equal across
the country, when divided into three regions: South 8/
32 (25.0%), Central 6/26 (23.1%) and North/Islands 8/35
(22.9%). The median within flock seroprevalence for T.
gondii on farms without vaccination was 55.5% (95% CI:
50.0, 65.2%) and on farms with vaccination 59.2% (95%
CI: 53.8, 82.7%). Statistical comparison revealed no sig-
nificant difference of median within-flock prevalence
between flocks with and without vaccination (p-value =
0.29). Consequently the full data set (n = 125) was used
for further analysis.
Age effect on T. gondii seroprevalence
The age of 3171 sheep was recorded. This allowed the
association between seroprevalence and age to be
assessed to determine if an increased cumulative chance
of environmental exposure to T. gondii will be reflected
in increased seroprevalence in older animals. Seroposi-
tivity for T. gondii increased with age from 37.7%, for
sheep that were about 1 year old, to 73.8%, for sheep
that were older than 6 years. The increasing T. gondii
seroprevalence with age is illustrated in Figure 2, while
the actual figures and percentages are shown in Table 1.
The regression coefficient for age predicting OD reading
was estimated to be 3.1 (standard error: 0.38, p-value: <
0.001). The frequency of borderline cases (n = 309) per
age group ranged from 5.5% to 11.7% of sheep per age
group but no age dependency was observed (Figure 2).
Regional variation in T. gondii prevalence
Toxoplasma gondii seroprevalence was calculated for
three separate regions of Scotland. The lowest T. gondii
seroprevalence was seen in the south of Scotland, where
the median within-flock prevalence was 42.3%, which
increased to 57.7% in central Scotland and was at its
highest with 69.2% in North/Islands as shown in Figure
3, whereby the difference between south and north was
statistically significant (p-value: < 0.001).
Risk factors
Univariate analysis identified several risk factors asso-
ciated with lambing and biosecurity as being associated
with higher and lower T. gondii seroprevalence values.
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Farms where lambing took place on pasture (n = 51)
had a median within-flock seroprevalence of T. gondii of
52.2%; farms where animals were housed during lamb-
ing (n = 56) had a within-flock prevalence of 54.4% but
farms where sheep were kept in paddocks or “parks”
during lambing (n = 18) had a significantly higher med-
ian within-flock prevalence of 78.3%. (p-value = 0.050).
These results are illustrated in Figure 4. Grazing of
sheep together with sheep from other farms on common
pasture was also identified as a potential risk factor (p-
value = 0.019). The mean within-flock prevalence for
farms, where sheep had no contact with sheep from
other farms, (n = 105) was 52.2%, while farms, where
sheep shared pasture with sheep from other farms, (n =
20) had a median within-flock prevalence of 72.6%.
Type of fencing (i.e. double versus single fence) of the
pasture did not have any significant effect on median
within-flock T. gondii seroprevalence but farms that
were contained by a single boundary (n = 70) had a
lower median within-flock seroprevalence (51.0%) than
Figure 1 Geographic distribution of 125 study farms across Scotland and their T. gondii seroprevalence. The circles map the location of
the study farms, according to their post code. The size of a circle is directly proportional to T. gondii seroprevalence within the corresponding
sample of the sheep flock. All farms had at least a single seropositive animal and in four farms all out of a sample of 27 animals tested positive
for T. gondii antibodies.
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farms with multiple boundaries (n = 55; 62.5%, p-value
= 0.027).
Multivariate analysis with region, common pasture,
mean sheep age, farm boundary and lambing location as
explanatory variables identified mean sheep age and
boundary consistently as significant risk factors for
within-flock T. gondii seroprevalence. The best fitting
model included region as an explanatory variable; how-
ever, deemed a proxy for geographic differences in flock
management, further models were run without region.
Common pasture consequently was identified as signifi-
cant factor, whilst lambing location made no significant
additional contribution to explain the variability
observed in seroprevalence. Sheep breed was not found
to be a significant factor for T. gondii seroprevalence.
Discussion
The results from this Scotland wide study showed an
overall seroprevalence for T. gondii in sheep of 56.6%.
Previous seroprevalence studies in Scotland, conducted
20 years ago, only examined animals from specific
regions where the prevalence of T. gondii in sheep from
locations around Glasgow was found to be 26.2% [27].
Results from our study showed an increase in T. gon-
dii seroprevalence with age confirming that a major
source of infection for sheep is likely to be through the
consumption of sporulated oocysts from the environ-
ment. This trend has also been reported by other
authors where seroprevalence to T. gondii in market
weight lambs was found to be only about half that of
adult ewes [12], reflecting an increase in seropositivity
with animal age. Further studies looking at development
of specific antibodies in sheep, as an indicator of expo-
sure to T. gondii, have shown that there is an increase
in seroprevalence associated with age indicating that
there is extensive environmental contamination with
Figure 2 T. gondii seroprevalence in sheep according to age of
animal. The percentage of sheep being T. gondii seropositive
increased from 37.3%, in animals that are one year old, to 73.8% in
animals that are more than 6 years old, while the number of
borderline samples stayed fairly unchanged for the different age
groups. Borderline cases were excluded from the calculation of the
age-related T. gondii seroprevalence.
Table 1 Seropositivity for Toxoplasma gondii in sheep according to animal age.
Age of Sheep Numbers of Animals Percentage of Animals
Positive Negative Borderline Positive* Negative* Borderline
1 year 76 128 12 37.3% 62.7% 5.6%
2 years 247 289 58 46.1% 53.9% 9.8%
3 years 351 307 87 53.3% 46.7% 11.7%
4 years 340 257 64 57.0% 43.0% 9.7%
5 years 292 151 45 65.9% 34.1% 9.2%
6 years 209 101 28 67.4% 32.6% 8.3%
> 6 years 104 37 15 73.8% 26.2% 9.6%
Total 1619 1270 309 56.0% 44.0% 9.7%
* Borderline results were excluded for calculation of seroprevalence in age cohorts
Figure 3 Within-flock T. gondii seroprevalence in study farms
stratified by geography. Southern (i.e. south of Glasgow and
Edinburgh), central (i.e. Aberdeenshire, Perthshire and Argyll) and
northern (i.e. Highlands and Islands) regions of Scotland. The
boxplots illustrate minimum and maximum, first and third quartiles
as well as median.
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T. gondii oocysts and that most infections in sheep
occur following birth [28-30]. These studies taken
together with the extensive study reported in this paper
do not support the hypothesis, based on a more limited
data set, that vertical transmission of T. gondii is signifi-
cant in sheep flocks [31]. This direct correlation of
increasing age and sero-prevalence has also been
described in humans [32-34].
During T. gondii infection animals mount a humoral
immune response which can be detected by measuring
immunoglobulin G (IgG) antibody levels. Following an
initial infection, antibody levels are expected to stay ele-
vated for the lifetime of the animal, because the immune
response of infected animals does not completely clear
the parasite and animals stay persistently infected. How-
ever, recent longitudinal serology based studies have
shown that T. gondii IgG antibody levels may drop in
some infected animals leading to false negative results
[35,36]. One of these studies followed 524 sheep for one
year and T. gondii antibody levels were measured at 4
different time points. Around 10% of the animals had
negative test results following a previously positive result
which raises issues about the sensitivity of some of the
serological assays used to measure T. gondii antibodies
and also the persistence of the elevated antibody titres
following infection.
This study revealed a significant positive correlation of
increasing T. gondii prevalence and age of animals
tested, reflecting an accumulation of T. gondii infection
throughout life. This study confirms that sheep in
Scotland are frequently exposed to T. gondii oocysts and
that horizontal transmission is a significant route of
infection. This observation provides further support to
previous papers stating that horizontal rather than verti-
cal transmission is the main cause of ovine abortion
[6,9,10,12,37]. Smaller increases in T. gondii prevalence,
observed between the older age groups are likely to
represent a decreasing number of naïve animals, in
these groups, that are still able to become infected. This
may yet be further confounded by some persistently
infected animals, without recent T. gondii challenge
becoming antibody negative as seen in longitudinal sero-
prevalence studies [35,36]. This effect will result in a
reduction of detection of infected animals, which will
particularly affect the older age groups. A reason, why
the higher rate of T. gondii seroconversion is seen in the
younger age groups, maybe due to the use of Toxovax®.
Analysis of the questionnaire data revealed that most
farmers tend to vaccinate replacement ewes, i.e. young
animals. The vaccine consists of a live attenuated strain
that does not cause persistent infection [11]. It induces
humoral and cell mediated immune responses that will
protect sheep very effectively for more than 18 month
against T. gondii induced abortions without the need for
booster vaccination or field challenge [11]. However,
detectable antibody levels may not persist for more than
six month without subsequent challenge [38]. Therefore,
an increased rate of seroconversion is likely to be seen
in the younger age groups. However, this effect is not
long lived, without field challenge, and did not result in
a significant difference in mean within flock difference
for vaccinated and non-vaccinated sheep due to mixed
ages of animals tested on each farm.
The results of this study show that there is a gradient
of T. gondii seroprevalence across Scotland, where the
South has a significantly lower mean within-flock sero-
prevalence (36.8%) than the North/Islands (60.5%), with
the Central part of Scotland having an intermediate ser-
oprevalence (54.8%). This result is independent of sheep
breed, which was not significantly associated with T.
gondii infection. The observed infection gradient is dif-
ferent to trends seen in other European studies, in
France [39] and Finland [40], where studies have shown
higher seroprevalence figures for the south of the coun-
tries and lower figures for the north. The French study
observed an increasing prevalence gradient from north-
western to southern France in sheep and explained this
due to more favourable conditions to oocyst survival
[39]. The Finnish study reported a geographical gradient
in T. gondii prevalence for sheep and moose, where the
seroprevalence in both host species was lower in the
North and higher in the South-Western part of Finland.
The authors suggested that this observation may reflect
areas of habitation and therefore cat density because
Figure 4 Within-flock T. gondii seroprevalence on 125 study
farms stratified by lambing location. Ewes housed for lambing
(House), lambing on restricted area outside (Paddock/Park) and
lambing on pasture (Pasture). The boxplots illustrate minimum and
maximum, first and third quartiles as well as median.
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T. gondii oocysts are very unlikely to survive the severe
Finnish winters. It is unlikely that the figures obtained
for Scotland reflect cat density or areas of habitation
alone but are also likely to involve minimum tempera-
tures during winter, which for the UK does not only
depend on a North-South gradient but may depend on
altitude and closeness to the coast and other large
bodies of water, which do not freeze during winter and
may aid oocyst survival during winter. In the absence of
severe winters in the UK, Ireland and New Zealand, it
has been speculated that oocyst may survive in the
environment for up to 18 month due to the mild and
humid climates in these countries [40]. Climate change
predictions of increasing temperatures, drier summers,
and wetter winters have lead to the speculation that
sporulated oocyst survival is likely to increase, leading to
an increase in T. gondii prevalence in intermediate and
final hosts [41]. The latter study focused on the effect
climate change on T. gondii prevalence in Europe and
predicted an increase in human toxoplasmosis cases that
will be higher in the South of England with only modest
increases in the North of England and Scotland. How-
ever, T. gondii prevalence figures in this survey would
indicate that sheep in the North of Scotland and the
Scottish Islands are either more susceptible hosts for T.
gondii, which seems unlikely, since no breed effect was
identified. An alternative reason is that there is more
environmental contamination by viable oocysts, which
may reflect more favourable conditions for oocysts sur-
vival or alternatively higher cat densities.
The analysis of the questionnaire has shown that the
practice of lambing in paddocks is a potential risk factor
leading to increased seropositivity in sheep flocks, which
could be explained by the proximity of these paddocks
to farm buildings and access by cats, which in turn may
lead to elevated levels of oocysts present in the pad-
docks as a source of infection for the sheep flock. A pre-
vious study identified grazing by lambs in close
proximity to farms as potential risk factor for T. gondii
infection and the authors recommended that lambs
should not be grazed near farms to lower exposure to
oocysts shed by cats [42]. Paddocks, in this study, are
likely to represent a similar risk factor. Variation in
lambing practices and cat densities may explain differ-
ences in T. gondii flock prevalence figures for farms are
geographically very close.
The questionnaire results also highlighted that there is
a relatively low (24.7%) uptake of the Toxovax® vaccine,
which protects ewes very effectively against T. gondii
associated abortion. All farms had sheep that were sero-
positive indicating that all flocks had exposure to T. gon-
dii and the potential of experiencing abortions induced
by this parasite. Analysis of the questionnaire data did
not allow identification of reasons for the low vaccine
uptake by farmers but it could be speculated that only
farmers that had previous abortion problems that were
caused by T. gondii used the vaccine. The low uptake of
this vaccine may also explain why T. gondii is still the
second most frequently detected abortifacient in ovine
abortions, according to current VIDA reports [2].
The high T. gondii seroprevalence in Scottish sheep
flocks indicate that a significant number of persistently
infected animals will enter the food chain. A recent sur-
vey identified that eating undercooked meat is not com-
monly seen as a risk factor for T. gondii infection by
people, only 30% of people asked, were aware of this
risk, while the majority recognised cats as risk [43]. In
Europe it has been well documented that a major source
of T. gondii infection for humans is ingestion of meat or
meat products containing T. gondii tissue cysts that
have not been inactivated, either by cooking or freezing
[16,17,22]. Vaccines that would have great potential ben-
eficial to both animal and public health would be those
that reduce or stop shedding of oocysts by cats [44,45]
or reduce T. gondii cyst formation in food animal spe-
cies [11,46,47], particular targets would be sheep and
pigs [12,43,46-48], while cattle seem to pose a lower risk
for transmission of T. gondii via infected meat [49].
The prevalence figures described in this study demon-
strate that T. gondii is widely distributed across sheep
flocks in Scotland, and that the within-flock prevalence
is not the same across Scotland but that it is higher in
the North and the Islands and significantly lower in
Southern Scotland. An increase in seroprevalence was
associated with increasing animal age, indicating that
acquired infection in life due to oocyst consumption is a
major route of transmission. The seroprevalence data
also indicates that contamination of the environment
with oocysts is high in Scotland and that sheep meat if
undercooked may pose a significant risk of T. gondii
transmission to people.
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